We aimed to provide practical recommendations for the screening of subclinical atrial
fibrillation (AF) in patients with ischaemic stroke or transient ischaemic attack (TIA) of …

Background and Purpose—Determining the underlying cause of stroke is important to
optimize secondary prevention treatment. Increased blood levels of natriuretic peptides (B …

Objective: To discover, by using metabolomics, novel candidate biomarkers for stroke
recurrence (SR) with a higher prediction power than present ones. Methods: Metabolomic …

Determining the cause of stroke is considered one of the main objectives in evaluating a
stroke patient in clinical practice. However, ischemic stroke is a heterogeneous disorder and …

Context: Various processes including inflammation and endothelial dysfunction have been
implicated in the pathogenesis of cardioembolic (CE) strokes. Objective: To review the …

Objectives The study of biomarkers related to the infarct volume of acute ischaemic stroke
(AIS) is a valuable clinical strategy. We conducted a prospective study to evaluate the …

Background and purpose There are currently no biomarkers to select cryptogenic stroke
(CS) patients for monitoring with insertable cardiac monitors (ICMs), the most effective tool …

Transient ischemic attacks (TIAs) before an acute ischemic stroke (AIS) could induce
ischemic tolerance (IT) phenomena. with an endogenous neuroprotective role (Ischemic …

Background Most approaches to transient ischaemic attack (TIA) triage use clinical scores
and vascular imaging; however, some biomarkers have been suggested to improve the …

Introduction: Ischemic tolerance (IT) refers to a state where cells are resistant to the
damaging effects caused by periods of ischemia. In a clinical scenario, the IT phenomenon …